Dopamine D3 receptor ligand suppresses the expression of levodopa-induced dyskinesia in nonhuman primate model of parkinson's disease

This publication has 72 references indexed in Scilit:

• A critique of available scales and presentation of the non‐human primate dyskinesia rating scale
  Movement Disorders, 2012
• Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
  Science, 2010
• Current perspectives on selective dopamine D₃receptor antagonists as pharmacotherapeutics for addictions and related disorders
  Annals of the New York Academy of Sciences, 2010
• Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease
  Neurobiology of Disease, 2009
• Dopamine D₂, D₃, and D₄Selective Phenylpiperazines as Molecular Probes To Explore the Origins of Subtype Specific Receptor Binding
  Journal of Medicinal Chemistry, 2009
• Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments
  European Neurology, 2008
• Long-distance potentials: an approach to the multiple-minima problem in ligand-receptor interaction
  Protein Engineering, Design and Selection, 1996
• Autoradiographic distribution of D3-type dopamine receptors in human brain using [3H]7-hydroxy-N,N-di-n-propyl-2-aminotetralin
  Brain Research, 1994
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics
  Nature, 1990
• Parkinsonism
  Neurology, 1967